InvestorsHub Logo

Jumpinjackas

03/30/16 12:31 PM

#19722 RE: AlaskaBushMan #19721

His pay won't be much... It's the cost to run trials.

Just like that TAUc3 guy. We are moving in the right direction.

john1045

03/30/16 1:30 PM

#19727 RE: AlaskaBushMan #19721

ABM....hopefully Mr. Maza has this already well planned with Shire Friedreich's Ataxia trail data being published and possible Orphan Drug Designation for FA plus royalty payment and/or acquisition of ILNS.